Sadaf Atarod Jean Norden Louis Bibby Dr Clare Lendrem Dr Kim Pearce et al. | Differential MicroRNA Expression Levels in Cutaneous Acute Graft-versus-Host Disease | 2018 |
|
Dr Marzena Ciechomska Dr Steven O'Reilly Professor Fiona Oakley Professor Jaap van Laar
| Histone Demethylation and Toll-like Receptor 8-Dependent Cross-Talk in Monocytes Promotes Transdifferentiation of Fibroblasts in Systemic Sclerosis Via Fra-2 | 2016 |
|
Dr Steven O'Reilly
| Pound the alarm: danger signals in rheumatic diseases | 2015 |
|
Dr Marzena Ciechomska Dr Steven O'Reilly Professor Jaap van Laar
| A novel role of MIR-29a in inhibition of TAB1-mediated timp-1 production in dermal fibroblasts: implication for SSC pathogenesis | 2014 |
|
Dr Marzena Ciechomska Professor Jaap van Laar Dr Steven O'Reilly
| Emerging role of epigenetics in systemic sclerosis pathogenesis | 2014 |
|
Dr Steven O'Reilly
| Innate immunity in systemic sclerosis pathogenesis | 2014 |
|
Dr Steven O'Reilly Dr Marzena Ciechomska Rachel Cant Professor Jaap van Laar
| Interleukin-6 (IL-6) Trans Signaling Drives a STAT3-dependent Pathway That Leads to Hyperactive Transforming Growth Factor-beta (TGF-beta) Signaling Promoting SMAD3 Activation and Fibrosis via Gremlin Protein | 2014 |
|
Dr Steven O'Reilly Rachel Cant Dr Marzena Ciechomska Professor Fiona Oakley Professor Sophie Hambleton et al. | Serum Amyloid A (SAA) induces IL-6 in dermal fibroblasts via TLR2, IRAK4 and NF-κB | 2014 |
|
Dr Steven O'Reilly Rachel Cant Dr Marzena Ciechomska James Finnigan Professor Fiona Oakley et al. | Serum amyloid A induces interleukin-6 in dermal fibroblasts via Toll-like receptor 2, interleukin-1 receptor-associated kinase 4 and nuclear factor-kappa B | 2014 |
|
Dr Lindsay Murphy Dr Saimir Luli Dr Lee Borthwick Dr Steven O'Reilly Professor Neil Perkins et al. | Inhibition of RelA-Ser536 phosphorylation by a competing peptide reduces mouse liver fibrosis without blocking the innate immune response | 2013 |
|
Dr Steven O'Reilly Rachel Cant Dr Marzena Ciechomska Professor Jaap Van Laar
| Interleukin-6: a new therapeutic target in systemic sclerosis? | 2013 |
|
Dr Catherine Stroud Dr Mario Abinun Dr Steven O'Reilly Dr Marzena Ciechomska Dr Stephen Owens et al. | Late Onset Invasive Pneumococcal Disease in a Patient with IRAK4 Deficiency | 2013 |
|
Dr Steven O'Reilly
| Role of interleukin-13 in fibrosis, particularly systemic sclerosis | 2013 |
|
Dr Marzena Ciechomska Rachel Cant James Finnigan Professor Jaap Van Laar Dr Steven O'Reilly et al. | Role of toll-like receptors in systemic sclerosis | 2013 |
|
Dr Nicola Fullard Dr Steven O'Reilly Professor Jaap Van Laar David Faini Julie Diboll et al. | The c-Rel Subunit of NF-κB Regulates Epidermal Homeostasis and Promotes Skin Fibrosis in Mice | 2013 |
|
Dr Thomas Huegle Dr Steven O'Reilly Rachel Simpson Dr Venetia Bigley Professor Matthew Collin et al. | Tumor Necrosis Factor-Costimulated T Lymphocytes From Patients With Systemic Sclerosis Trigger Collagen Production in Fibroblasts | 2013 |
|
Dr Marzena Ciechomska Christiaan Huigens Dr Andreas Gessner Dr Steven O'Reilly Professor Jaap Van Laar et al. | A novel role of monocytes in the induction of profibrotic tissue-inhibitor of metalloproteinase-1 mediated by toll-like receptors stimulation in SSC | 2012 |
|
Nadine Binai Dr Steven O'Reilly Dr Bridget Griffiths Professor Jaap Van Laar
| Differentiation Potential of CD14(+) Monocytes into Myofibroblasts in Patients with Systemic Sclerosis | 2012 |
|
Dr Steven O'Reilly Dr Marzena Ciechomska Professor Jaap Van Laar
| Interleukin-6, its role in fibrosing conditions | 2012 |
|
Dr Steven O'Reilly Dr Bridget Griffiths Dr Anja Krippner-Heidenreich Professor Jaap Van Laar
| T cell derived IL-6 and IL-13 drive fibroblast fibrosis: Implications for systemic sclerosis | 2012 |
|
Dr Steven O'Reilly Professor Jaap Van Laar
| T cells in systemic sclerosis: a reappraisal | 2012 |
|
Dr Marzena Ciechomska Dr Steven O'Reilly
| TOLL-LIKE RECEPTOR-MEDIATED EXPRESSION OF PROFIBROTIC MEDIATORS BY CIRCULATING MONOCYTES IN SYSTEMIC SCLEROSIS | 2012 |
|
Dr Marzena Ciechomska Dr Andreas Gessner Dr Steven O'Reilly Professor Jaap Van Laar
| Toll-like receptor-mediated expression of profibrotic tissue-inhibitor of metalloproteinase-1 by circulating monocytes in Systemic sclerosis | 2012 |
|
Dr Steven O'Reilly Dr Venetia Bigley Professor Matthew Collin Dr Anja Krippner-Heidenreich Professor Jaap van Laar et al. | Tumor necrosis factor-alpha co-activated T-cells support a profibrotic cytokine milieu on cost of IL-10 expression in patients with systemic sclerosis | 2012 |
|
Dr Steven O'Reilly
| Inducers of Cross-Linked Actin Networks (CLANs) in Trabecular Meshwork Cells | 2011 |
|
Dr Steven O'Reilly Dr Thomas Huegle Dr Anja Krippner-Heidenreich Professor Jaap Van Laar
| T cell-derived IL-6 and IL-13 drive dermal fibrosis: implications for systemic sclerosis | 2011 |
|
Dr Thomas Huegle Dr Anja Krippner-Heidenreich Rachel Simpson Dr Steven O'Reilly Dr Venetia Bigley et al. | Tumour necrosis factor alpha receptor activated T cells of patients with systemic sclerosis are deficient in IL-10 expression but promote myofibroblast differentiation via IL-6 and TGF-beta | 2011 |
|
Dr Steven O'Reilly
| Cross-Linked Actin Networks (CLANs) are presnet in lamina cribrosa cells | 2010 |
|
Dr Steven O'Reilly
| Cross-Linked Actin Networks (CLANs) in bovine trabecular meshwork cells | 2009 |
|
Dr Mark Verrill Dr Steven O'Reilly
| TEXAS (Taxotere (R) EXperience with Anthracyclines Study) trial: mature results of activity/toxicity of docetaxel given with anthracyclines in a community setting, as first line therapy for MBC | 2007 |
|
Wei Zhang Professor Fraser Birrell Christopher McCarthy Dr Steven O'Reilly
| Evidence-based recommendations for the role of exercise in the management of osteoarthritis of the hip or knee - The MOVE concensus | 2005 |
|